Cordis Hit With $22M Verdict In Stent Patent Case
The jury in U.S. District Court for the District of Minnesota returned its verdict Monday, following a trial that began on Jan. 13. The jury found that the infringement of a single patent by Cordis and stent manufacturer Norman Noble Inc. was willful.
The jury rejected the defendants' argument that the patent at issue was invalid....
To view the full article, register now.